604 related articles for article (PubMed ID: 25151981)
21. Cell entry of cell penetrating peptides: tales of tails wagging dogs.
Jones AT; Sayers EJ
J Control Release; 2012 Jul; 161(2):582-91. PubMed ID: 22516088
[TBL] [Abstract][Full Text] [Related]
22. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
23. Oral biodrug delivery using cell-penetrating peptide.
Khafagy el-S; Morishita M
Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
[TBL] [Abstract][Full Text] [Related]
24. CPP-Assisted Intracellular Drug Delivery, What Is Next?
Ye J; Liu E; Yu Z; Pei X; Chen S; Zhang P; Shin MC; Gong J; He H; Yang VC
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854260
[TBL] [Abstract][Full Text] [Related]
25. Strategies to stabilize cell penetrating peptides for in vivo applications.
Fominaya J; Bravo J; Rebollo A
Ther Deliv; 2015; 6(10):1171-94. PubMed ID: 26448473
[TBL] [Abstract][Full Text] [Related]
26. Cell-penetrating peptides: possibilities and challenges for drug delivery in vitro and in vivo.
Skotland T; Iversen TG; Torgersen ML; Sandvig K
Molecules; 2015 Jul; 20(7):13313-23. PubMed ID: 26205056
[TBL] [Abstract][Full Text] [Related]
27. Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.
Kang T; Gao X; Chen J
Curr Pharm Biotechnol; 2014; 15(3):220-30. PubMed ID: 24938893
[TBL] [Abstract][Full Text] [Related]
28. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
Li H; Tsui TY; Ma W
Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
[TBL] [Abstract][Full Text] [Related]
29. Cell penetrating peptides for tumor targeting.
Choi YS; Lee JY; Suh JS; Lee SJ; Yang VC; Chung CP; Park YJ
Curr Pharm Biotechnol; 2011 Aug; 12(8):1166-82. PubMed ID: 21470141
[TBL] [Abstract][Full Text] [Related]
30. 1988-2018: Thirty years of drug smuggling at the nano scale. Challenges and opportunities of cell-penetrating peptides in biomedical research.
Gallo M; Defaus S; Andreu D
Arch Biochem Biophys; 2019 Jan; 661():74-86. PubMed ID: 30447207
[TBL] [Abstract][Full Text] [Related]
31. Covalent attachment of cyclic TAT peptides to GFP results in protein delivery into live cells with immediate bioavailability.
Nischan N; Herce HD; Natale F; Bohlke N; Budisa N; Cardoso MC; Hackenberger CP
Angew Chem Int Ed Engl; 2015 Feb; 54(6):1950-3. PubMed ID: 25521313
[TBL] [Abstract][Full Text] [Related]
32. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
[TBL] [Abstract][Full Text] [Related]
33. Cell penetrating peptides in ocular drug delivery: State of the art.
Pescina S; Ostacolo C; Gomez-Monterrey IM; Sala M; Bertamino A; Sonvico F; Padula C; Santi P; Bianchera A; Nicoli S
J Control Release; 2018 Aug; 284():84-102. PubMed ID: 29913221
[TBL] [Abstract][Full Text] [Related]
34. Cell-penetrating peptides for drug delivery across membrane barriers.
Foged C; Nielsen HM
Expert Opin Drug Deliv; 2008 Jan; 5(1):105-17. PubMed ID: 18095931
[TBL] [Abstract][Full Text] [Related]
35. Direct cytosolic delivery of cargoes in vivo by a chimera consisting of D- and L-arginine residues.
Ma Y; Gong C; Ma Y; Fan F; Luo M; Yang F; Zhang YH
J Control Release; 2012 Sep; 162(2):286-94. PubMed ID: 22824782
[TBL] [Abstract][Full Text] [Related]
36. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
[TBL] [Abstract][Full Text] [Related]
37. Cyclic Cell-Penetrating Peptides as Efficient Intracellular Drug Delivery Tools.
Park SE; Sajid MI; Parang K; Tiwari RK
Mol Pharm; 2019 Sep; 16(9):3727-3743. PubMed ID: 31329448
[TBL] [Abstract][Full Text] [Related]
38. Rational design of CPP-based drug delivery systems: considerations from pharmacokinetics.
Mickan A; Sarko D; Haberkorn U; Mier W
Curr Pharm Biotechnol; 2014; 15(3):200-9. PubMed ID: 25312539
[TBL] [Abstract][Full Text] [Related]
39. Cell-penetrating Peptides for Cancer-targeting Therapy and Imaging.
Wang W; Abbad S; Zhang Z; Wang S; Zhou J; Lv H
Curr Cancer Drug Targets; 2015; 15(4):337-51. PubMed ID: 25669720
[TBL] [Abstract][Full Text] [Related]
40. [The development of cell-penetrating peptides in drug delivery system].
Fan B; Jin MJ; Huang W; Wang QM; Gao ZG
Yao Xue Xue Bao; 2016 Feb; 51(2):264-71. PubMed ID: 29856580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
